Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

National Health Investors, Inc. (WX6.F)

Compare
65.50
-0.50
(-0.76%)
At close: April 4 at 9:55:02 PM GMT+2
Loading Chart for WX6.F
  • Previous Close 66.00
  • Open 65.50
  • Bid 65.50 x 4700
  • Ask 66.00 x 4700
  • Day's Range 65.00 - 65.50
  • 52 Week Range 53.50 - 79.00
  • Volume 50
  • Avg. Volume 10
  • Market Cap (intraday) 2.993B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 23.06
  • EPS (TTM) 2.84
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 3.33 (5.08%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est --

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

www.nhireit.com

30

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WX6.F

View More

Performance Overview: WX6.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

WX6.F
1.98%
S&P 500 (^GSPC)
13.73%

1-Year Return

WX6.F
26.85%
S&P 500 (^GSPC)
1.42%

3-Year Return

WX6.F
51.55%
S&P 500 (^GSPC)
10.72%

5-Year Return

WX6.F
170.23%
S&P 500 (^GSPC)
103.89%

Compare To: WX6.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WX6.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    2.96B

  • Enterprise Value

    3.97B

  • Trailing P/E

    23.11

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.52

  • Price/Book (mrq)

    2.42

  • Enterprise Value/Revenue

    13.08

  • Enterprise Value/EBITDA

    16.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    41.12%

  • Return on Assets (ttm)

    4.63%

  • Return on Equity (ttm)

    10.28%

  • Revenue (ttm)

    335.58M

  • Net Income Avi to Common (ttm)

    137.87M

  • Diluted EPS (ttm)

    2.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.54M

  • Total Debt/Equity (mrq)

    92.14%

  • Levered Free Cash Flow (ttm)

    168.26M

Research Analysis: WX6.F

View More

Company Insights: WX6.F

Research Reports: WX6.F

View More

People Also Watch